AI Image
Treatment for stiff person syndrome shows promising early results
USA Today • • health
Key Points:
- A new study published in JAMA Neurology reveals promising early results for treating stiff person syndrome (SPS) using CAR-T cell therapy, which modifies a patient's immune cells to target disease cells.
- Researchers observed substantial improvement in some patients, with notable recovery of function rarely seen with existing treatments, though long-term effects remain uncertain.
- SPS is a rare neurological disorder characterized by progressive muscle stiffness, spasms, and rigidity, often triggered by environmental factors like sudden movement or loud noises.
- Patients treated with CAR-T therapy reported significant improvements, including regained mobility and the ability to resume daily activities and work.
- The high-profile diagnosis of singer Celine Dion has brought attention to SPS, a condition she has battled since 2022 with various treatments, highlighting the need for more effective therapies.
